Trial Profile
Clinical trial to evaluate the influence of 6 day-dexamethasone (inducer of CES1) co-administration on the pharmacokinetics of oseltamivir in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Dexamethasone
- Indications Influenza virus infections
- Focus Pharmacokinetics
- 08 Sep 2016 New trial record